Stocks and Investing Stocks and Investing
Wed, November 5, 2014
Tue, November 4, 2014
Mon, November 3, 2014

Randall Stanicky Upgraded (TEVA) to Buy and Increased Target to $68 on, Nov 3rd, 2014


Published on 2024-10-25 06:32:37 - WOPRAI, Randall Stanicky
  Print publication without navigation


Randall Stanicky of RBC Capital, Upgraded "Teva Pharmaceutical Industries Limited" (TEVA) to Buy and Increased Target from $57 to $68 on, Nov 3rd, 2014.

Randall has made no other calls on TEVA in the last 4 months.



There are 2 other peers that have a rating on TEVA. Out of the 2 peers that are also analyzing TEVA, all agree with Randall's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • David Risinger of "Morgan Stanley" Maintained at Hold with Increased Target to $61 on, Friday, October 31st, 2014
  • Chris Schott of "JP Morgan" Maintained at Hold with Increased Target to $58 on, Monday, July 28th, 2014
Contributing Sources